These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 8424687)

  • 1. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
    Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
    Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
    Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
    Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction.
    Liu CZ; Huang TF
    Arch Biochem Biophys; 1997 Jan; 337(2):291-9. PubMed ID: 9016825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of fibronectin, Von Willebrand factor, and fibrinogen in platelet interaction with solid substrata.
    Lahav J; Hynes RO
    J Supramol Struct Cell Biochem; 1981; 17(4):299-311. PubMed ID: 6977039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitronectin binds to activated human platelets and plays a role in platelet aggregation.
    Asch E; Podack E
    J Clin Invest; 1990 May; 85(5):1372-8. PubMed ID: 1692034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrin alpha 2 beta 1 (GPIa/IIa)-I-domain inhibits platelet-collagen interaction.
    Depraetere H; Wille C; Gansemans Y; Stanssens P; Lauwereys M; Baruch D; De Reys S; Deckmyn H
    Thromb Haemost; 1997 May; 77(5):981-5. PubMed ID: 9184414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel 33-kDa C1q-binding site on human blood platelets.
    Peerschke EI; Reid KB; Ghebrehiwet B
    J Immunol; 1994 Jun; 152(12):5896-901. PubMed ID: 8207215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function.
    McLane MA; Gabbeta J; Rao AK; Beviglia L; Lazarus RA; Niewiarowski S
    Thromb Haemost; 1995 Nov; 74(5):1316-22. PubMed ID: 8607116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
    Cox AD; Devine DV
    Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
    Frojmovic MM; Wong T; Searcy GP
    Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.